TB-500 vs BPC-157: Which Healing Peptide is Right for You?

If you've spent any time in the peptide community, you've seen this question come up a hundred times: TB-500 or BPC-157? Both are healing peptides. Both have enthusiastic followings. And both show up in nearly every recovery-focused protocol. But they work differently, they're dosed differently, and they shine in different situations.

This guide breaks down the real differences — not just the theoretical mechanisms, but what actually matters when you're deciding which one to run (or whether to stack both).

What is BPC-157?

BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide derived from a protective protein found in human gastric juice. It was first isolated in the early 1990s, and research has been steadily accumulating since then — mostly in animal models, but the volume of positive findings is hard to ignore.

Its primary mechanism involves upregulating growth factor expression — particularly VEGF (vascular endothelial growth factor), which promotes new blood vessel formation. It also modulates the nitric oxide system, has anti-inflammatory properties, and appears to accelerate tendon-to-bone healing in animal studies.

What makes BPC-157 distinctive is its localized action. While it has systemic effects, many researchers inject it as close to the injury site as possible, and anecdotal reports consistently describe targeted healing responses. It's also one of the few peptides that shows oral bioavailability — it was originally studied as an oral agent for gut healing.

What is TB-500?

TB-500 is a synthetic version of a naturally occurring 43-amino-acid peptide called Thymosin Beta-4. It's found in virtually every cell in the human body and plays a fundamental role in cell migration, blood vessel formation, and tissue repair.

TB-500 works through a systemic mechanism. Its primary action involves upregulating actin, a cell-building protein that's essential for cell migration and proliferation. When tissue is damaged, TB-500 helps recruit cells to the injury site and promotes the formation of new blood vessels and tissue matrix.

Unlike BPC-157, TB-500 doesn't need to be injected near the injury. It's a systemic peptide — inject it subcutaneously anywhere, and it circulates throughout the body. This makes it particularly useful for multiple injury sites or general recovery support.

Head-to-Head Comparison

Dosing Protocols

BPC-157 Dosing

The standard research dose for BPC-157 is 250–500 mcg per day, injected subcutaneously. Most people start at 250 mcg and assess response before moving to 500 mcg. A 5mg vial at 250 mcg/day lasts 20 days — at 500 mcg/day, 10 days.

Timing: Once daily is standard, though some protocols split the dose to twice daily (e.g., 250 mcg morning and evening). Inject as close to the injury site as practical. For gut issues, oral BPC-157 capsules are an option.

Cycle length: 4–6 weeks is typical, followed by 2–4 weeks off. Some run it longer for chronic issues. Read our full BPC-157 dosage guide for detailed protocols.

TB-500 Dosing

TB-500 uses a loading/maintenance protocol. The loading phase is typically 2–2.5 mg injected twice per week for 4–6 weeks. After that, a maintenance dose of 2–2.5 mg once per week is common.

The higher per-dose amount is because TB-500 is a larger peptide and works systemically. The less frequent dosing reflects its longer biological half-life compared to BPC-157.

When to Use Each

Choose BPC-157 when:

• You have a specific, localized injury (tendon, ligament, joint)
• Gut healing is a priority (IBS, leaky gut, NSAID damage)
• Budget is a concern — daily dosing is cheaper per week than TB-500 loading
• You want the option of oral administration
• You prefer daily consistent dosing over less frequent injections

Choose TB-500 when:

• You have multiple injury sites or general systemic inflammation
• Muscle tears or cardiac recovery are the focus
• You prefer fewer injections per week
• The injury site is hard to reach for localized injection
• You're looking for broader recovery and flexibility support

Stacking TB-500 + BPC-157

This is where it gets interesting. The BPC-157 + TB-500 stack is arguably the most popular healing peptide combination, and for good reason: their mechanisms are complementary, not redundant.

BPC-157 upregulates VEGF and promotes angiogenesis (new blood vessel formation). TB-500 upregulates actin and promotes cell migration. Together, you get both the "build new blood supply" signal and the "recruit repair cells" signal working simultaneously.

Typical stack protocol:

• BPC-157: 250–500 mcg daily, injected near injury site
• TB-500: 2–2.5 mg twice weekly (loading) or once weekly (maintenance)
• Duration: 4–8 weeks

Many vendors also sell pre-made BPC-157/TB-500 blends, which simplify the process but reduce your ability to adjust doses independently.

Side Effects

Both peptides have relatively mild side effect profiles based on available research:

BPC-157: Injection site redness, occasional nausea (more common with oral), mild headache. Some report temporary lethargy during the first few days. Serious adverse effects are rare in research literature.

TB-500: Head rush shortly after injection, mild fatigue, occasional flu-like symptoms during loading phase. Some report temporary lethargy. These typically resolve within the first week.

The Bottom Line

There's no universal winner here. BPC-157 is the better choice for targeted, localized healing — especially tendons, joints, and gut. TB-500 is better for systemic recovery, muscle injuries, and situations where you can't inject near the problem area.

If budget allows and you're dealing with a significant injury, the stack is worth considering. The complementary mechanisms provide a more complete healing response than either peptide alone.

For detailed dosing math, use our reconstitution calculator. And explore both peptides in our research library: BPC-157 | TB-500.